Robert Stanton, MD
Orthopaedic Surgery · Fairfield, CTNPI 1912919978
Payments from drug & device makers
What this record shows
This record is dominated by other: $197,056 of the $199,248 with a category attached, or 98.9%. Linvatec Corporation accounts for 98.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $93,564 and has fallen 56.9% since, to $40,281 in 2025. Among orthopaedic surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $14,232 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$197K
- Biorez, Inc.$2K
- Pacira Therapeutics, Inc.$173
- Biohorizons Implant Systems Inc.$19
What the payments were for
- Consulting fees$2,0001%
- Speaking & faculty fees$500%
- Food & beverage$1420%
- Other$197,05699%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 9 | $197,056 |
| Biorez, Inc. | 2 | $2,000 |
| Pacira Therapeutics, Inc. | 2 | $173 |
| Biohorizons Implant Systems Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioBrace 23mm$199,056
- BioBrace 5mm$2,000
- Zilretta$123
How this compares
$199,248 in reported general payments places this provider in the 95th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Fairfield
- John AwadFairfield$65K
- Peter WhangNew Haven$1.8M
- Paul SethiGreenwich$1.5M
- James YueShelton$1.3M
- Robert DeveneyDanbury$907K
- James PaceFarmington$721K
- Isaac MossFarmington$676K
- David FrumbergNew Haven$288K
- John KeggiMiddlebury$264K
- Lauren GeaneyFarmington$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.